IDYA — IDEAYA Biosciences Inc. stock price and chart

Share this page

IDYA

$32.85-2.95%

as of close, Oct 16, 2026

☾ AH $32.85 -2.95%

IDEAYA Biosciences Inc.Stock · HealthcareRussell 2000 0.10%Nasdaq Composite 0.008%US Stock Market 0.005%Russell 3000 0.004%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

Available history since May 29, 2019

VolumeEEEE

20192021202320242026

5.010.015.020.025.030.035.040.045.0010.0M$32.85

2026-10-16

Price$32.85

MA20$37.31

MA50$34.22

Vol655.1K

What would $1,000 invested in IDYA be worth today? →

IDYA returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $32.85
YTD price return: -4.98%
YTD total return: -4.98%
Next earnings: Nov 3, 2026
Market cap: 3.2B2019-09 183M2026-10 3.2B+1633.8% over the window
Enterprise value: 2.4B
Shares outstanding: 96.5M2018-12 1.3M2026-06 96.5M+7123.9% over the window
52W low: $26.81
52W high: $42.68
From 52W high: -23.03%
From 52W low: +22.53%
52W range: 38%

Volume

Rel volume: 0.78×
30D volume: 835.5K
30D $ vol: 31M

Fundamentals

Sales (ttm): 234.1M2019-12 02026-06 234.1M
Sales/share: $2.432019-12 $0.002026-06 $2.43
EPS (ttm): -$1.952020-12 -$1.402026-06 -$1.95+39.3% over the window
FCF (ttm): -113.9M2017-12 -14M2026-06 -113.9M+714.5% over the window
FCF/share: -$1.182018-12 -$21.962026-06 -$1.18-94.6% over the window
Book value/share: $12.432018-06 -$21.002026-06 $12.43-159.2% over the window
Net margin: -74.75%2020-12 -176.6%2026-06 -74.8%-57.7% over the window
ROE: -14.60%2019-06 -34.7%2026-06 -14.6%-57.9% over the window
ROA: -13.36%2018-12 -35.6%2026-06 -13.4%-62.4% over the window
Current ratio: 10.452018-12 16.752026-06 10.45-37.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: n/a+73.07%2023-06-30 → 2026-06-3045.1M → 234.1M (+418.6% total)+45.80%2021-06-30 → 2026-06-3035.5M → 234.1M (+558.8% total)n/a
Shares: +10.10%2025-06-30 → 2026-06-3087.6M → 96.5M (+10.1% total)+18.79%2023-06-30 → 2026-06-3057.6M → 96.5M (+67.6% total)+20.24%2021-06-30 → 2026-06-3038.4M → 96.5M (+151.3% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share: n/a+45.70%2023-06-30 → 2026-06-30$0.78 → $2.43 (+209.4% total)+21.26%2021-06-30 → 2026-06-30$0.93 → $2.43 (+162.2% total)n/a
Book value/share: +13.49%2025-06-30 → 2026-06-30$10.95 → $12.43 (+13.5% total)+12.55%2023-06-30 → 2026-06-30$8.71 → $12.43 (+42.6% total)+14.71%2021-06-30 → 2026-06-30$6.26 → $12.43 (+98.6% total)n/a
Price: +18.65%2025-10-16 → 2026-10-16$27.69 → $32.85 (+18.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+10.13%2023-10-16 → 2026-10-16$24.59 → $32.85 (+33.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+7.27%2021-10-15 → 2026-10-16$23.13 → $32.85 (+42.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +18.65%2025-10-16 → 2026-10-16$27.69 → $32.85 (+18.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+10.13%2023-10-16 → 2026-10-16$24.59 → $32.85 (+33.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+7.27%2021-10-15 → 2026-10-16$23.13 → $32.85 (+42.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -16.8×2019-09 -4.602026-10 -18.13+293.8% over the window
Fwd P/E: -9.0×
P/S (ttm)Market cap ÷ TTM revenue.: 13.5×2020-12 23.122026-10 13.55-41.4% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.6×2019-09 1.662026-10 2.65+59.7% over the window
EV/Sales (ttm): 10.1×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -3.59%2019-06 -21.1%2026-06 -3.2%-85.0% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 96.5M ÷ 87.6M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -10.10%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-10.10%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -10.10%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-183.2M) ÷ today's market cap ($3.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -5.78%2019-06 -27.8%2026-06 -5.1%-81.6% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-183.2M + TTM dividends $0) ÷ today's market cap ($3.2B). Same caveat as the cash buyback yield.: -5.78%2019-06 -27.8%2026-06 -5.1%-81.6% over the window

Vs own 10Y history

P/S: 13th
P/B: 57th

Bar = where today’s multiple sits in IDYA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-2.95%

-9.03%

-12.93%

-8.57%

YTD

-4.98%

+18.63%

+42.02%

Financial statements

Open full IDYA financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

IDYA — IDEAYA Biosciences Inc. price, chart and key statistics